{"id":"W2589081531","doi":"","title":"In vitro combination studies of Troxacitabine (Troxatyl™, SGX-145) against human tumor cell lines.","year":2006,"lang":"en","type":"article","venue":"","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Clonogenic assay; Doxorubicin; Antagonism; Paclitaxel; Pharmacology; Cancer; Combination therapy; Medicine; Breast cancer; Cancer cell; Bone cancer; Cancer research; Bone metastasis; Metastasis; Chemotherapy; In vitro; Chemistry; Internal medicine; Receptor; Biochemistry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006043291,0.0006257366,0.001129377,0.0005062809,0.0002615494,0.0004148115,0.0003727631,0.0003853378,0.001887296],"category_scores_gemma":[0.0001996779,0.0002732239,0.0005826853,0.0006407861,0.0001519929,0.0002690735,0.0002314528,0.000683431,0.0006280895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003764523,"about_ca_system_score_gemma":0.0004511611,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00260315,"about_ca_topic_score_gemma":0.004538048,"domain_scores_codex":[0.9994718,0.0001548606,0.00006063258,0.00009168282,0.0001561442,0.00006482285],"domain_scores_gemma":[0.999798,0.0000525478,0.00003102364,0.00002615935,0.00005398929,0.00003831153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001030903,0.00108311,0.0009075289,0.0005433087,0.00009367586,0.0001733119,0.0001783752,0.0008937611,0.9824799,0.0002111008,0.001011211,0.01139376],"study_design_scores_gemma":[0.0002012342,0.01465323,0.009208013,0.00003778293,0.0002266327,0.0006458394,0.0001102865,0.002325486,0.9599521,0.00004705431,0.0125672,0.00002534483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9605917,0.02460559,0.003643985,0.0003495793,0.0004351115,0.0004237251,0.002415466,0.0001748837,0.007359831],"genre_scores_gemma":[0.9691186,0.0118415,0.007582117,0.0001718471,0.0001077796,0.0003694022,0.003580348,0.000037507,0.007190909],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00260315,"threshold_uncertainty_score":0.006313622,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02556507897193268,"score_gpt":0.3421897571300715,"score_spread":0.3166246781581389,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}